Please provide your email address to receive an email when new articles are posted on . A meta-analysis revealed high risks for TB recurrence/relapse and mortality during treatment with tobacco use.

Tuberculosis (TB) can transmit via the air, and the risk of infection depends on several factors. These can include the duration of exposure, proximity to a person with the infection, and immune ...

Researcher found that exposed individuals with confirmed TB infection -- i.e. a positive skin or blood test -- should receive priority treatment in settings with a low prevalence of the disease, ...

Treating all household contacts of someone with tuberculosis (TB) helped prevent active TB disease across age groups in the real world, but the effectiveness was highest when treating individuals who ...

The mycobacteria that typically cause lung tuberculosis (TB) can also cause gastrointestinal (GI) TB. This condition typically requires prompt treatment with anti-tuberculous drugs. GI TB can involve ...

Without a correct diagnosis and treatment, tuberculosis can sometimes be a serious, potentially life threatening infection. However, with the right steps, it is curable. Tuberculosis (TB) is a ...

Disseminated tuberculosis (TB) occurs when the infection has spread through your blood to other parts of your body. This causes widespread symptoms that may include abdominal pain, night sweats, and ...

A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases. At the Wits Advanced Drug Delivery Platform (WADDP), postdoctoral researcher Dr.

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

"In our study of US-bound immigrants in Vietnam during their required overseas medical examination prior to migration to the United States, we identified a high proportion of US-bound immigrants with ...

The novel antibiotic candidate sorfequiline has the potential to shorten and improve tuberculosis (TB) treatment when combined with pretomanid and linezolid (SPaL), according to new clinical trial ...